Speakers

Stacy Cline Amin, J.D.

Vice President, Chief Counsel for Global Health Regulatory & Policy, Oracle — United States

Helmy Eltoukhy, Ph.D

Co-Founder, Chairman & Co-CEO, Guardant Health — United States

George Poste, D.V.M., Ph.D.

Regents’ Professor & Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University — United States

Susanne Munksted

Chief Precision Medicine Officer, Diaceutics — United States/Global

David Morrow, Ph.D.

Scientific Lead for Advanced Therapies, EATRIS — Europe

Daryl Pritchard, Ph.D.

Senior Vice President, Science Policy, Personalized Medicine Coalition — United States

AmirAli Talasaz

Co-Founder & Co-CEO, Guardant Health — United States

Tomasz Beer, M.D.

Vice President & Chief Medical Officer, Multi-Cancer Early Detection, Exact Sciences — United States

Omar Perez, Ph.D.

U.S. Head of Medical Diagnostics, AstraZeneca — United States

Laura Carter, Ph.D.

Chief Scientific Officer, Character Biosciences — United States

Yaik Ho, Ph.D.

Head of Strategy, Oncology Data Science & AI, AstraZeneca — United Kingdom

Kristin Ciriello Pothier

Life Sciences Sector & Deal Advisory Leader, KPMG — United States

Jonathan Katchmore

Associate Vice President, Commercial Diagnostic Strategy, Eli Lilly — United States

Brad Perkins, M.D.

Chief Medical Officer, Karius — United States

Aradhana Ghosh, M.D.

Vice President, Real-World Data Product Development, Labcorp — United States